glp 1 agonists addiction Not just obesity: GLP-1 receptor advance on GLP-1 Receptor Agonists in Addiction

These medications exert (in)direct hepatic actions by reducing steatosis, attenuating inflammation, and potentially reversing fibrosis, while simultaneously addressing systemic metabolic abnormalities including excessive obesity, insulin resistance, and cardiovascular risk

The global obesity treatment market is expanding at unprecedented speed, with sales of weight-loss medications forecast to rise dramatically over the next decade.

Learn how GLP-1s can positively impact your wellness journey.

To help people figure out who qualifies, whats involved and what to expect for first-time GLP-1 users, a pair of weight management specialists at MUSC Health sat down for this Q&A.

There have been and continue to be advances in the GLP-1 pipeline.

Obesity is a chronic disease associated with many complications